Monday, January 9, 2023

< + > The FDA Approved The New Anti-Alzheimer’s Drug Leqembi. What You Need To Know

A trial found the drug slowed the progression of early-stage Alzheimer’s Disease.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > Enriching Psychiatric Evaluations with AI – Life Sciences Today Podcast Episode 67

We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Iris Shtein, Co-F...